ANDA 202792, held by Actavis Elizabeth. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 202792 (Clonidine Hydrochloride), held by Actavis Elizabeth, was first approved by FDA on May 15, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 15, 2015 | Original application | Approved | None posted |
| Clonidine Hydrochloride0.1MG · tablet, extended release;oral | Clonidine Hydrochloride | Discontinued |
| Clonidine Hydrochloride0.2MG · tablet, extended release;oral | Clonidine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters